A03AA04 - mebeverine : Belongs to the class of synthetic anticholinergics, esters with tertiary amino group. Used in the treatment of functional bowel disorders.
A03AA04 - mebeverine : Belongs to the class of synthetic anticholinergics, esters with tertiary amino group. Used in the treatment of functional bowel disorders.
(chocolate flavor) 850 g x 1's (vanilla/wheat/coffee flavor) 800 g x 1's (chocolate/strawberry flavor) 400 g x 1's (vanilla/wheat/coffee flavor) 380 g x 1's
MIMS Class
Enteral/Nutritional Products
ATC Classification
V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations : Used as general nutrients.
((vanilla flavor)) 1.2 kg x 1's ((vanilla flavor)) 1110 g x 1's ((vanilla flavor)) 380 g x 1's ((vanilla flavor)) 800 g x 1's ((vanilla flavor)) 850 g x 1's ((vanilla flavor)) 400 g x 1's
MIMS Class
Enteral/Nutritional Products
ATC Classification
V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations : Used as general nutrients.
C08DA01 - verapamil : Belongs to the class of phenylalkylamine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
V01AA03 - house dust mites : Belongs to the class of allergen extracts. Used as antigenic substances capable of producing immediate-type hypersensitivity.
G03AA12 - drospirenone and ethinylestradiol : Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
L01CA04 - vinorelbine : Belongs to the class of plant alkaloids and other natural products, vinca alkaloids and analogues. Used in the treatment of cancer.
L01CA04 - vinorelbine : Belongs to the class of plant alkaloids and other natural products, vinca alkaloids and analogues. Used in the treatment of cancer.
R03AL01 - fenoterol and ipratropium bromide : Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
R03AL01 - fenoterol and ipratropium bromide : Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
R03AL01 - fenoterol and ipratropium bromide : Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
R03AL02 - salbutamol and ipratropium bromide : Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
A10BD19 - linagliptin and empagliflozin : Belongs to the class of combinations of oral blood glucose lowering drugs. Used in the treatment of diabetes.
A10BD19 - linagliptin and empagliflozin : Belongs to the class of combinations of oral blood glucose lowering drugs. Used in the treatment of diabetes.
C09DA07 - telmisartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA07 - telmisartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
R03AL06 - olodaterol and tiotropium bromide : Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
C09DB04 - telmisartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DB04 - telmisartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DB04 - telmisartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DA06 - candesartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA06 - candesartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA09 - azilsartan medoxomil and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DB07 - candesartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
A10BH - Dipeptidyl peptidase 4 (DPP-4) inhibitors : Belongs to the class of dipeptidyl peptidase 4 (DPP-4) inhibitors. Used in the treatment of diabetes.
L01FD04 - trastuzumab deruxtecan : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
L02BX03 - abiraterone : Belongs to the class of other hormone antagonists and related agents. Used in the treatment of metastatic castration-resistant prostate cancer.
A10AD04 - insulin lispro : Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.
A10AD04 - insulin lispro : Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.
A10AD04 - insulin lispro : Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.
L01CB01 - etoposide : Belongs to the class of plant alkaloids and other natural products, podophyllotoxin derivatives. Used in the treatment of cancer.
G03AA15 - chlormadinone and ethinylestradiol : Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
G03AA13 - norelgestromin and ethinylestradiol : Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
M01AB15 - ketorolac : Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products.
R03AL03 - vilanterol and umeclidinium bromide : Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
G04CA52 - tamsulosin and dutasteride : Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.
inactivated type 1 poliomyelitis virus, inactivated type 3 poliomyelitis virus, inactivated type 2 poliomyelitis virus, filamentous haemagglutinin, diphtheria toxoid, pertussis toxoid, hepatitis B surface antigen, tetanus toxoid, pertactin, Haemophilus influenzae type b capsular polysaccharide
Packing/Price
0.5 mL x 2's
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07CA09 - diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B : Belongs to the class of combined bacterial and viral vaccines.
R03AK10 - vilanterol and fluticasone furoate : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
R03AK10 - vilanterol and fluticasone furoate : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
R03AK06 - salmeterol and fluticasone : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
R03AK06 - salmeterol and fluticasone : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
R03AK06 - salmeterol and fluticasone : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
R03AK06 - salmeterol and fluticasone : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
R03AK06 - salmeterol and fluticasone : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
R03AK06 - salmeterol and fluticasone : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
R03AL08 - vilanterol, umeclidinium bromide and fluticasone furoate : Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
J05AB11 - valaciclovir : Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
C08CA04 - nicardipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA04 - nicardipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA04 - nicardipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
A02BC01 - omeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
C01CA03 - norepinephrine : Belongs to the class of adrenergic and dopaminergic cardiac stimulants excluding glycosides. Used in the treatment of hypotension.
J01CR05 - piperacillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01DD62 - cefoperazone and beta-lactamase inhibitor : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
J01DD62 - cefoperazone and beta-lactamase inhibitor : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
A12AA, V03AE01 - Calcium, polystyrene sulfonate : Used as dietary supplements., Belongs to the class of drugs used in the treatment of hyperkalemia and hyperphosphatemia.
A07XA03, V03AE01 - calcium compounds, polystyrene sulfonate : Belongs to the class of other antidiarrheals., Belongs to the class of drugs used in the treatment of hyperkalemia and hyperphosphatemia.
R05FA02 - opium derivatives and expectorants : Belongs to the class of combinations of opium derivatives cough suppressants and expectorants. Used in the treatment of cough.
L01FF02 - pembrolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
J01DI54 - ceftolozane and beta-lactamase inhibitor : Belongs to the class of other cephalosporins and penems. Used in the systemic treatment of infections.
C09DA03 - valsartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA03 - valsartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA03 - valsartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA03 - valsartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA03 - valsartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA03 - valsartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DX04 - valsartan and sacubitril : Belongs to the class of angiotensin II receptor blockers (ARBs), other combinations. Used in the treatment of cardiovascular disease.
C09DX04 - valsartan and sacubitril : Belongs to the class of angiotensin II receptor blockers (ARBs), other combinations. Used in the treatment of cardiovascular disease.
C09DX04 - valsartan and sacubitril : Belongs to the class of angiotensin II receptor blockers (ARBs), other combinations. Used in the treatment of cardiovascular disease.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
Angiotensin II Antagonists, Calcium Antagonists, Diuretics
ATC Classification
C09DX01 - valsartan, amlodipine and hydrochlorothiazide : Belongs to the class of angiotensin II receptor blockers (ARBs), other combinations. Used in the treatment of cardiovascular disease.
Angiotensin II Antagonists, Calcium Antagonists, Diuretics
ATC Classification
C09DX01 - valsartan, amlodipine and hydrochlorothiazide : Belongs to the class of angiotensin II receptor blockers (ARBs), other combinations. Used in the treatment of cardiovascular disease.
V03AC03 - deferasirox : Belongs to the class of iron chelating agents. Used in the management of chronic iron overload associated with blood transfusion.
L01EH01 - lapatinib : Belongs to the class of human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors. Used in the treatment of cancer.
A10AD06 - insulin degludec and insulin aspart : Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.
A10AE56 - insulin degludec and liraglutide : Belongs to the class of long-acting insulins and analogues for injection. Used in the treatment of diabetes.
C10BA05 - atorvastatin and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
C10BA05 - atorvastatin and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
C10BA05 - atorvastatin and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
C09DA01 - losartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA01 - losartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA01 - losartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
G03AA09 - desogestrel and ethinylestradiol : Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
G03AA09 - desogestrel and ethinylestradiol : Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
G03AA09 - desogestrel and ethinylestradiol : Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
G03AA09 - desogestrel and ethinylestradiol : Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
C10BA02 - simvastatin and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
C10BA02 - simvastatin and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
C10BA02 - simvastatin and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
R03AC02 - salbutamol : Belongs to the class of adrenergic inhalants, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
R03CC08 - procaterol : Belongs to the class of adrenergics for systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
R03CC08 - procaterol : Belongs to the class of adrenergics for systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
R03CC08 - procaterol : Belongs to the class of adrenergics for systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
L01EK01 - axitinib : Belongs to the class of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
L01EK01 - axitinib : Belongs to the class of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Angiotensin II Antagonists, Anti-Anginal Drugs, Calcium Antagonists
ATC Classification
C09DB02 - olmesartan medoxomil and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
Angiotensin II Antagonists, Anti-Anginal Drugs, Calcium Antagonists
ATC Classification
C09DB02 - olmesartan medoxomil and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
Angiotensin II Antagonists, Anti-Anginal Drugs, Calcium Antagonists
ATC Classification
C09DB02 - olmesartan medoxomil and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DA08 - olmesartan medoxomil and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
C09DA08 - olmesartan medoxomil and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
J01CR05 - piperacillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR04 - sultamicillin : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR01 - ampicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR01 - ampicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01DD52 - ceftazidime and beta-lactamase inhibitor : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
S01GA07, S01EA05 - brimonidine, brimonidine : Belongs to the class of sympathomimetics used as ophthalmologic decongestants., Belongs to the class of sympathomimetics used in the treatment of glaucoma.
C08CA13 - lercanidipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA13 - lercanidipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA13 - lercanidipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA13 - lercanidipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
L02BX03 - abiraterone : Belongs to the class of other hormone antagonists and related agents. Used in the treatment of metastatic castration-resistant prostate cancer.
L02BX03 - abiraterone : Belongs to the class of other hormone antagonists and related agents. Used in the treatment of metastatic castration-resistant prostate cancer.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
A02BC04 - rabeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC04 - rabeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
inactivated type 1 poliomyelitis virus, inactivated type 3 poliomyelitis virus, inactivated type 2 poliomyelitis virus, filamentous haemagglutinin, diphtheria toxoid, pertussis toxoid, Haemophilus influenzae type b polysaccharide conjugated, hepatitis B surface antigen, tetanus toxoid
Packing/Price
0.5 mL x 1's
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07CA09 - diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B : Belongs to the class of combined bacterial and viral vaccines.
meningococcal polysaccharide (group A, C, Y, W-135) tetanus toxoid conjugate vaccine
Packing/Price
1's
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07AH08 - meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated : Belongs to the class of meningococcal bacterial vaccines.
C01CA03 - norepinephrine : Belongs to the class of adrenergic and dopaminergic cardiac stimulants excluding glycosides. Used in the treatment of hypotension.
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC06 - dexlansoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC06 - dexlansoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
B02BD06 - von Willebrand factor and coagulation factor VIII in combination : Belongs to the class of blood coagulation factors. Used in the treatment of hemorrhage.
B02BD06 - von Willebrand factor and coagulation factor VIII in combination : Belongs to the class of blood coagulation factors. Used in the treatment of hemorrhage.
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC03 - lansoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC03 - lansoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC03 - lansoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
B02BD01 - coagulation factor IX, II, VII and X in combination : Belongs to the class of blood coagulation factors. Used in the treatment of hemorrhage.
A02BC08 - vonoprazan : Belongs to the class of potassium-competitive acid blocker. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC08 - vonoprazan : Belongs to the class of potassium-competitive acid blocker. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
V01AA03 - house dust mites : Belongs to the class of allergen extracts. Used as antigenic substances capable of producing immediate-type hypersensitivity.
G03AA15 - chlormadinone and ethinylestradiol : Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
G03AA13 - norelgestromin and ethinylestradiol : Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
C08CA13 - lercanidipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA13 - lercanidipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA13 - lercanidipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA13 - lercanidipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
L01FD04 - trastuzumab deruxtecan : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
L01FF02 - pembrolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
R03AC02 - salbutamol : Belongs to the class of adrenergic inhalants, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
L02BX03 - abiraterone : Belongs to the class of other hormone antagonists and related agents. Used in the treatment of metastatic castration-resistant prostate cancer.
L02BX03 - abiraterone : Belongs to the class of other hormone antagonists and related agents. Used in the treatment of metastatic castration-resistant prostate cancer.
Sign Out
d7c73c27-0c9a-45b6-aeca-a82300cc22ac.GIF)
 liqd 250 mL518461f4-6684-49cc-967f-a97c00adf496.GIF)
 20 mge5e83b5a-cecd-42da-8eee-b06801086add.GIF)
 30 mg8ef771b6-ca64-45a8-bb16-b06801086b02.GIF)
 100 mgf9106a94-dd70-4834-872f-b00c0102328f.GIF)
 25 mgb6e225a3-832e-4d73-bd31-b00c01023299.GIF)
a771d53e-63be-49b8-9d3a-afe1013cffee.GIF)
3298cef2-b5ff-45ed-9719-afe1013e65be.GIF)
b77cd649-b6c0-44a2-8278-a5cb0135d6a4.GIF)
cc429510-7143-46d9-a65f-ab74012c11f9.GIF)
6cbd0f51-7628-48ea-979d-ab74012c1260.GIF)
b68ff9d8-3e4a-46ab-9e68-a5b400e7eefb.GIF)
6234fed9-82f6-4b2a-873b-a5b400e1a1f8.GIF)
48c090dc-ff3c-4d24-9074-a8bf0102ed24.GIF){kind=spacer}
f032f20b-dc49-4af2-aa98-a8bf0102ed8b.GIF){kind=spacer}
387a0ed9-1a6d-43a6-b916-a8bf0102edfb.GIF){kind=spacer}
 0.5 mL05101bd0-3d4b-466a-bbdd-adb8011200f8.GIF)
a299b76f-23fe-444c-9955-ac56008c6194.GIF)
e2deb975-7388-498d-bf0a-a4d700b364e1.GIF)
7d9b63ae-d1c4-4541-a65e-a5b400f6f1f6.GIF)
e535cf3e-e6b9-4da2-8338-9fab00229f90.GIF)
